HEADER HYDROLASE/HYDROLASE INHIBITOR 18-JAN-21 7LFU TITLE CRYSTAL STRUCTURE OF THE SARS COV-1 PAPAIN-LIKE PROTEASE IN COMPLEX TITLE 2 WITH PEPTIDE INHIBITOR VIR250 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PAPAIN-LIKE PROTEASE; COMPND 3 CHAIN: D; COMPND 4 SYNONYM: PP1A,ORF1A POLYPROTEIN; COMPND 5 EC: 3.4.19.12,3.4.22.-,3.4.22.69; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PAPAIN-LIKE PROTEASE PEPTIDE INHIBITOR VIR250; COMPND 9 CHAIN: A; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS; SOURCE 3 ORGANISM_COMMON: SARS-COV; SOURCE 4 ORGANISM_TAXID: 694009; SOURCE 5 GENE: 1A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL-21(DE3) RIL CODON PLUS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 14 ORGANISM_TAXID: 32630 KEYWDS COVID-19, CORONAVIRUS, SARS, COV-1, COV-2, PAPAIN-LIKE PROTEASE, KEYWDS 2 PLPRO, DEUBIQUITINATING ENZYME, UBIQUITIN, ACTIVITY-BASED PROBE, KEYWDS 3 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.K.OLSEN,Z.LV REVDAT 3 15-NOV-23 7LFU 1 LINK ATOM REVDAT 2 18-OCT-23 7LFU 1 REMARK REVDAT 1 10-NOV-21 7LFU 0 JRNL AUTH S.PATCHETT,Z.LV,W.RUT,M.BEKES,M.DRAG,S.K.OLSEN,T.T.HUANG JRNL TITL A MOLECULAR SENSOR DETERMINES THE UBIQUITIN SUBSTRATE JRNL TITL 2 SPECIFICITY OF SARS-COV-2 PAPAIN-LIKE PROTEASE. JRNL REF CELL REP V. 36 09754 2021 JRNL REFN ESSN 2211-1247 JRNL PMID 34547223 JRNL DOI 10.1016/J.CELREP.2021.109754 REMARK 2 REMARK 2 RESOLUTION. 2.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 70.73 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 16663 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1668 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 70.7310 - 5.2422 1.00 1352 151 0.1978 0.2360 REMARK 3 2 5.2422 - 4.1610 1.00 1282 141 0.1730 0.1898 REMARK 3 3 4.1610 - 3.6351 1.00 1264 141 0.2159 0.2290 REMARK 3 4 3.6351 - 3.3027 1.00 1259 140 0.2506 0.3355 REMARK 3 5 3.3027 - 3.0660 1.00 1250 139 0.2699 0.3257 REMARK 3 6 3.0660 - 2.8852 1.00 1244 139 0.2901 0.3639 REMARK 3 7 2.8852 - 2.7407 1.00 1232 137 0.2856 0.3566 REMARK 3 8 2.7407 - 2.6214 1.00 1241 138 0.2893 0.4033 REMARK 3 9 2.6214 - 2.5205 1.00 1229 136 0.3272 0.3896 REMARK 3 10 2.5205 - 2.4335 1.00 1245 140 0.3208 0.3829 REMARK 3 11 2.4335 - 2.3574 1.00 1239 138 0.3531 0.3667 REMARK 3 12 2.3574 - 2.2900 0.93 1158 128 0.3603 0.3802 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.400 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.980 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 74.36 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 91.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 2507 REMARK 3 ANGLE : 0.499 3398 REMARK 3 CHIRALITY : 0.037 379 REMARK 3 PLANARITY : 0.003 432 REMARK 3 DIHEDRAL : 14.819 1466 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'D' AND (RESID 5 THROUGH 62 ) REMARK 3 ORIGIN FOR THE GROUP (A): 65.6820 32.9955 11.2804 REMARK 3 T TENSOR REMARK 3 T11: 0.6749 T22: 0.8741 REMARK 3 T33: 0.6749 T12: -0.0771 REMARK 3 T13: 0.0807 T23: 0.0833 REMARK 3 L TENSOR REMARK 3 L11: 5.3244 L22: 8.5663 REMARK 3 L33: 5.5685 L12: -4.6022 REMARK 3 L13: -1.3762 L23: 0.6043 REMARK 3 S TENSOR REMARK 3 S11: 0.3152 S12: -1.2036 S13: -0.3182 REMARK 3 S21: 0.4611 S22: 0.1223 S23: 0.6517 REMARK 3 S31: -0.6751 S32: -0.4089 S33: -0.3466 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'D' AND (RESID 63 THROUGH 176 ) REMARK 3 ORIGIN FOR THE GROUP (A): 88.9708 28.3146 15.5237 REMARK 3 T TENSOR REMARK 3 T11: 0.6594 T22: 0.6329 REMARK 3 T33: 0.5877 T12: 0.0860 REMARK 3 T13: 0.0284 T23: 0.1935 REMARK 3 L TENSOR REMARK 3 L11: 6.2287 L22: 3.0661 REMARK 3 L33: 2.8341 L12: 1.7894 REMARK 3 L13: 3.1191 L23: 1.6880 REMARK 3 S TENSOR REMARK 3 S11: 0.1188 S12: -0.2849 S13: -0.0470 REMARK 3 S21: -0.0590 S22: 0.0323 S23: 0.4365 REMARK 3 S31: 0.1408 S32: -0.3564 S33: -0.1032 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'D' AND (RESID 177 THROUGH 231 ) REMARK 3 ORIGIN FOR THE GROUP (A): 109.5391 7.7262 17.3900 REMARK 3 T TENSOR REMARK 3 T11: 0.9909 T22: 0.6202 REMARK 3 T33: 0.9104 T12: 0.1522 REMARK 3 T13: -0.0554 T23: 0.1660 REMARK 3 L TENSOR REMARK 3 L11: 5.5369 L22: 5.9455 REMARK 3 L33: 4.0552 L12: 1.7415 REMARK 3 L13: -2.0580 L23: 3.5851 REMARK 3 S TENSOR REMARK 3 S11: -0.1525 S12: -0.3970 S13: -1.4479 REMARK 3 S21: 0.8942 S22: 0.1110 S23: -0.6367 REMARK 3 S31: 1.1484 S32: 0.2085 S33: 0.1052 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN 'D' AND (RESID 232 THROUGH 313 ) REMARK 3 ORIGIN FOR THE GROUP (A): 109.8682 26.8209 19.3916 REMARK 3 T TENSOR REMARK 3 T11: 0.5376 T22: 0.5604 REMARK 3 T33: 0.6427 T12: 0.1009 REMARK 3 T13: -0.0286 T23: 0.0631 REMARK 3 L TENSOR REMARK 3 L11: 3.5671 L22: 7.7725 REMARK 3 L33: 2.8996 L12: -0.4123 REMARK 3 L13: -0.3263 L23: 1.4084 REMARK 3 S TENSOR REMARK 3 S11: 0.0119 S12: -0.2551 S13: -0.3130 REMARK 3 S21: 0.1243 S22: 0.1314 S23: -0.9016 REMARK 3 S31: 0.2951 S32: 0.3193 S33: -0.1331 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7LFU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1000254230. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-SEP-20 REMARK 200 TEMPERATURE (KELVIN) : 108 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-E REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.32 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16767 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.290 REMARK 200 RESOLUTION RANGE LOW (A) : 70.731 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.29 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.80 REMARK 200 R MERGE FOR SHELL (I) : 2.14700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6WUU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM THIOCYANATE, AND 20% W/V REMARK 280 POLYETHYLENE GLYCOL 3350, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 35.38750 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 45.20400 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 56.78150 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 35.38750 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 45.20400 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 56.78150 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 35.38750 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 45.20400 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 56.78150 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 35.38750 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 45.20400 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 56.78150 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14550 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 PEPTIDE COVALENTLY LINKED TO ACTIVE SITE CYS REMARK 400 REMARK 400 THE PAPAIN-LIKE PROTEASE PEPTIDE INHIBITOR VIR250 IS PEPTIDE-LIKE, REMARK 400 A MEMBER OF ENZYME INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: PAPAIN-LIKE PROTEASE PEPTIDE INHIBITOR VIR250 REMARK 400 CHAIN: A REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET D 0 REMARK 465 GLU D 1 REMARK 465 VAL D 2 REMARK 465 LYS D 3 REMARK 465 CYS D 225 REMARK 465 VAL D 226 REMARK 465 CYS D 227 REMARK 465 THR D 314 REMARK 465 ILE D 315 REMARK 465 LYS D 316 REMARK 465 PRO D 317 REMARK 465 LEU D 318 REMARK 465 GLU D 319 REMARK 465 HIS D 320 REMARK 465 HIS D 321 REMARK 465 HIS D 322 REMARK 465 HIS D 323 REMARK 465 HIS D 324 REMARK 465 HIS D 325 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS D 158 O LEU D 163 2.05 REMARK 500 OE2 GLU D 281 OH TYR D 284 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA D 108 126.81 -172.59 REMARK 500 HIS D 192 40.65 -145.52 REMARK 500 PRO D 249 104.35 -57.61 REMARK 500 LYS D 280 -103.27 -124.83 REMARK 500 THR D 309 -72.90 -130.32 REMARK 500 REMARK 500 REMARK: NULL DBREF 7LFU D 1 317 UNP P0C6U8 R1A_SARS 1541 1856 DBREF 7LFU A 1 5 PDB 7LFU 7LFU 1 5 SEQADV 7LFU MET D 0 UNP P0C6U8 INITIATING METHIONINE SEQADV 7LFU LEU D 318 UNP P0C6U8 EXPRESSION TAG SEQADV 7LFU GLU D 319 UNP P0C6U8 EXPRESSION TAG SEQADV 7LFU HIS D 320 UNP P0C6U8 EXPRESSION TAG SEQADV 7LFU HIS D 321 UNP P0C6U8 EXPRESSION TAG SEQADV 7LFU HIS D 322 UNP P0C6U8 EXPRESSION TAG SEQADV 7LFU HIS D 323 UNP P0C6U8 EXPRESSION TAG SEQADV 7LFU HIS D 324 UNP P0C6U8 EXPRESSION TAG SEQADV 7LFU HIS D 325 UNP P0C6U8 EXPRESSION TAG SEQRES 1 D 325 MET GLU VAL LYS THR ILE LYS VAL PHE THR THR VAL ASP SEQRES 2 D 325 ASN THR ASN LEU HIS THR GLN LEU VAL ASP MET SER MET SEQRES 3 D 325 THR TYR GLY GLN GLN PHE GLY PRO THR TYR LEU ASP GLY SEQRES 4 D 325 ALA ASP VAL THR LYS ILE LYS PRO HIS VAL ASN HIS GLU SEQRES 5 D 325 GLY LYS THR PHE PHE VAL LEU PRO SER ASP ASP THR LEU SEQRES 6 D 325 ARG SER GLU ALA PHE GLU TYR TYR HIS THR LEU ASP GLU SEQRES 7 D 325 SER PHE LEU GLY ARG TYR MET SER ALA LEU ASN HIS THR SEQRES 8 D 325 LYS LYS TRP LYS PHE PRO GLN VAL GLY GLY LEU THR SER SEQRES 9 D 325 ILE LYS TRP ALA ASP ASN ASN CYS TYR LEU SER SER VAL SEQRES 10 D 325 LEU LEU ALA LEU GLN GLN LEU GLU VAL LYS PHE ASN ALA SEQRES 11 D 325 PRO ALA LEU GLN GLU ALA TYR TYR ARG ALA ARG ALA GLY SEQRES 12 D 325 ASP ALA ALA ASN PHE CYS ALA LEU ILE LEU ALA TYR SER SEQRES 13 D 325 ASN LYS THR VAL GLY GLU LEU GLY ASP VAL ARG GLU THR SEQRES 14 D 325 MET THR HIS LEU LEU GLN HIS ALA ASN LEU GLU SER ALA SEQRES 15 D 325 LYS ARG VAL LEU ASN VAL VAL CYS LYS HIS CYS GLY GLN SEQRES 16 D 325 LYS THR THR THR LEU THR GLY VAL GLU ALA VAL MET TYR SEQRES 17 D 325 MET GLY THR LEU SER TYR ASP ASN LEU LYS THR GLY VAL SEQRES 18 D 325 SER ILE PRO CYS VAL CYS GLY ARG ASP ALA THR GLN TYR SEQRES 19 D 325 LEU VAL GLN GLN GLU SER SER PHE VAL MET MET SER ALA SEQRES 20 D 325 PRO PRO ALA GLU TYR LYS LEU GLN GLN GLY THR PHE LEU SEQRES 21 D 325 CYS ALA ASN GLU TYR THR GLY ASN TYR GLN CYS GLY HIS SEQRES 22 D 325 TYR THR HIS ILE THR ALA LYS GLU THR LEU TYR ARG ILE SEQRES 23 D 325 ASP GLY ALA HIS LEU THR LYS MET SER GLU TYR LYS GLY SEQRES 24 D 325 PRO VAL THR ASP VAL PHE TYR LYS GLU THR SER TYR THR SEQRES 25 D 325 THR THR ILE LYS PRO LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 A 5 ACE UB4 DPP GLY GVE HET ACE A 1 3 HET UB4 A 2 15 HET DPP A 3 6 HET GVE A 5 8 HETNAM ACE ACETYL GROUP HETNAM UB4 (2S)-2-AMINO-4-(1,3-BENZOTHIAZOL-2-YL)BUTANOIC ACID HETNAM DPP DIAMINOPROPANOIC ACID HETNAM GVE METHYL 4-AMINOBUTANOATE FORMUL 2 ACE C2 H4 O FORMUL 2 UB4 C11 H12 N2 O2 S FORMUL 2 DPP C3 H8 N2 O2 FORMUL 2 GVE C5 H11 N O2 HELIX 1 AA1 THR D 27 GLY D 33 1 7 HELIX 2 AA2 HIS D 48 GLU D 52 5 5 HELIX 3 AA3 ASP D 62 HIS D 74 1 13 HELIX 4 AA4 ASP D 77 LYS D 92 1 16 HELIX 5 AA5 ASN D 111 GLN D 122 1 12 HELIX 6 AA6 ALA D 130 ARG D 141 1 12 HELIX 7 AA7 ALA D 145 SER D 156 1 12 HELIX 8 AA8 ASP D 165 LEU D 174 1 10 HELIX 9 AA9 GLN D 175 ALA D 177 5 3 HELIX 10 AB1 VAL D 203 ALA D 205 5 3 HELIX 11 AB2 SER D 213 GLY D 220 1 8 SHEET 1 AA1 5 HIS D 18 VAL D 22 0 SHEET 2 AA1 5 ILE D 6 THR D 11 -1 N THR D 10 O HIS D 18 SHEET 3 AA1 5 THR D 55 VAL D 58 1 O PHE D 56 N PHE D 9 SHEET 4 AA1 5 THR D 35 LEU D 37 -1 N TYR D 36 O PHE D 57 SHEET 5 AA1 5 ALA D 40 ASP D 41 -1 O ALA D 40 N LEU D 37 SHEET 1 AA2 2 GLN D 98 VAL D 99 0 SHEET 2 AA2 2 LEU D 102 THR D 103 -1 O LEU D 102 N VAL D 99 SHEET 1 AA3 4 LYS D 196 THR D 201 0 SHEET 2 AA3 4 LYS D 183 VAL D 189 -1 N ARG D 184 O LEU D 200 SHEET 3 AA3 4 THR D 232 GLU D 239 -1 O TYR D 234 N ASN D 187 SHEET 4 AA3 4 VAL D 221 SER D 222 -1 N VAL D 221 O GLN D 233 SHEET 1 AA4 4 LYS D 196 THR D 201 0 SHEET 2 AA4 4 LYS D 183 VAL D 189 -1 N ARG D 184 O LEU D 200 SHEET 3 AA4 4 THR D 232 GLU D 239 -1 O TYR D 234 N ASN D 187 SHEET 4 AA4 4 SER D 310 THR D 312 -1 O TYR D 311 N GLN D 238 SHEET 1 AA5 7 MET D 207 MET D 209 0 SHEET 2 AA5 7 PHE D 242 LEU D 254 1 O SER D 246 N TYR D 208 SHEET 3 AA5 7 TYR D 297 LYS D 307 -1 O VAL D 304 N MET D 245 SHEET 4 AA5 7 CYS D 261 GLY D 267 -1 N CYS D 261 O PHE D 305 SHEET 5 AA5 7 GLY D 272 ALA D 279 -1 O THR D 275 N GLU D 264 SHEET 6 AA5 7 LEU D 283 ASP D 287 -1 O TYR D 284 N THR D 278 SHEET 7 AA5 7 HIS D 290 MET D 294 -1 O THR D 292 N ARG D 285 SSBOND 1 CYS D 190 CYS D 193 1555 1555 2.03 LINK SG CYS D 112 CB GVE A 5 1555 1555 1.82 LINK C ACE A 1 N UB4 A 2 1555 1555 1.45 LINK C UB4 A 2 N DPP A 3 1555 1555 1.45 LINK C DPP A 3 N GLY A 4 1555 1555 1.45 LINK C GLY A 4 N GVE A 5 1555 1555 1.45 CRYST1 70.775 90.408 113.563 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014129 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011061 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008806 0.00000